Cargando…
Metoprolol Mitigates Ischemic Heart Remodeling and Fibrosis by Increasing the Expression of AKAP5 in Ischemic Heart
The harm of heart failure mainly causes patients to develop dyspnea, fatigue, fluid retention, and other symptoms, which impair patients' activity tolerance and lead to a dramatic decrease in patients' quality of life. The purpose of this study was to verify whether metoprolol regulates AK...
Autores principales: | Zhu, Feng, Wang, Qiushu, Wang, Zhi, Zhang, Xu, Zhang, Benkai, Wang, Hegui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553363/ https://www.ncbi.nlm.nih.gov/pubmed/36238650 http://dx.doi.org/10.1155/2022/5993459 |
Ejemplares similares
-
Retracted: Metoprolol Mitigates Ischemic Heart Remodeling and Fibrosis by Increasing the Expression of AKAP5 in Ischemic Heart
por: Longevity, Oxidative Medicine and Cellular
Publicado: (2023) -
Mechanisms of the Beneficial Actions of Ischemic Preconditioning on
Subcellular Remodeling in Ischemic-Reperfused Heart
por: Müller, By Alison L, et al.
Publicado: (2010) -
Mitochondrial Metabolism in Myocardial Remodeling and Mechanical Unloading: Implications for Ischemic Heart Disease
por: Jiang, Min, et al.
Publicado: (2021) -
Cardioprotection by early metoprolol- attenuation of ischemic vs. reperfusion injury?
por: Kleinbongard, Petra
Publicado: (2020) -
AKAP5 and AKAP12 Form Homo-oligomers
por: Gao, Shujuan, et al.
Publicado: (2011)